Operating Lease, Right-of-Use Asset in USD of KEWAUNEE SCIENTIFIC CORP /DE/ from Q2 2019 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
KEWAUNEE SCIENTIFIC CORP /DE/ quarterly Operating Lease, Right-of-Use Asset history and change rate from Q2 2019 to Q2 2025.
  • KEWAUNEE SCIENTIFIC CORP /DE/ Operating Lease, Right-of-Use Asset for the quarter ending 31 Jul 2025 was $12M, a 73.1% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

KEWAUNEE SCIENTIFIC CORP /DE/ Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 $12M +$5.08M +73.1% 31 Jul 2025 10-Q 12 Sep 2025
Q1 2025 $13M +$5.51M +73.9% 30 Apr 2025 10-Q 12 Sep 2025
Q4 2024 $14M +$6.15M +78.5% 31 Jan 2025 10-Q 14 Mar 2025
Q3 2024 $6.94M -$1.45M -17.3% 31 Oct 2024 10-Q 13 Dec 2024
Q2 2024 $6.94M -$1.67M -19.4% 31 Jul 2024 10-Q 13 Sep 2024
Q1 2024 $7.45M -$1.72M -18.7% 30 Apr 2024 10-K 02 Jul 2025
Q4 2023 $7.83M -$1.74M -18.2% 31 Jan 2024 10-Q 08 Mar 2024
Q3 2023 $8.39M -$1.52M -15.3% 31 Oct 2023 10-Q 08 Dec 2023
Q2 2023 $8.61M -$343K -3.83% 31 Jul 2023 10-Q 01 Sep 2023
Q1 2023 $9.17M +$1.6M +21.1% 30 Apr 2023 10-K 28 Jun 2024
Q4 2022 $9.56M +$1.56M +19.4% 31 Jan 2023 10-Q 10 Mar 2023
Q3 2022 $9.91M +$1.45M +17.2% 31 Oct 2022 10-Q 09 Dec 2022
Q2 2022 $8.96M +$117K +1.32% 31 Jul 2022 10-Q 09 Sep 2022
Q1 2022 $7.57M -$1.71M -18.4% 30 Apr 2022 10-K 30 Jun 2023
Q4 2021 $8.01M -$1.71M -17.6% 31 Jan 2022 10-Q 11 Mar 2022
Q3 2021 $8.45M -$703K -7.68% 31 Oct 2021 10-Q 17 Dec 2021
Q2 2021 $8.84M +$10K +0.11% 31 Jul 2021 10-Q 10 Sep 2021
Q1 2021 $9.28M -$33K -0.35% 30 Apr 2021 10-K 01 Jul 2022
Q4 2020 $9.72M -$1.42M -12.7% 31 Jan 2021 10-Q 12 Mar 2021
Q3 2020 $9.16M -$925K -9.18% 31 Oct 2020 10-Q 11 Dec 2020
Q2 2020 $8.83M +$2.04M +30.1% 31 Jul 2020 10-Q 11 Sep 2020
Q1 2020 $9.31M 30 Apr 2020 10-K 15 Jul 2021
Q4 2019 $11.1M 31 Jan 2020 10-Q 13 Mar 2020
Q3 2019 $10.1M 31 Oct 2019 10-Q 16 Dec 2019
Q2 2019 $6.79M 31 Jul 2019 10-Q 06 Sep 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.